Åke Borg
361 – 370 of 397
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 1996
-
Mark
Urokinase plasminogen activator, a strong independent prognostic factor in breast cancer, analysed in steroid receptor cytosols with a luminometric immunoassay
(
- Contribution to journal › Article
-
Mark
Allelic loss at chromosome 13q12-q13 is associated with poor prognosis in familial and sporadic breast cancer
(
- Contribution to journal › Article
-
Mark
A novel p53 germline alteration identified in a late onset breast cancer kindred
(
- Contribution to journal › Article
-
Mark
Novel germline p16 mutation in familial malignant melanoma in southern Sweden
(
- Contribution to journal › Article
-
Mark
Genetic predisposition to breast cancer
(
- Contribution to journal › Article
-
Mark
Multiple splicing variants of the estrogen receptor are present in individual human breast tumors
(
- Contribution to journal › Article
- 1995
-
Mark
Recurrence-free survival in breast cancer improved by adjuvant tamoxifen--especially for progesterone receptor positive tumors with a high proliferation
(
- Contribution to journal › Article
-
Mark
TP53 mutations and breast cancer prognosis : particularly poor survival rates for cases with mutations in the zinc-binding domains
(
- Contribution to journal › Article
-
Mark
A Collaborative Survey of 80 Mutations in the BRCA1 Breast and Ovarian Cancer Susceptibility Gene : Implications for Presymptomatic Testing and Screening
(
- Contribution to journal › Article
- 1994
-
Mark
Cathepsin D, both a prognostic factor and a predictive factor for the effect of adjuvant tamoxifen in breast cancer. South Sweden Breast Cancer Group
(
- Contribution to journal › Article